UPTRAVI

Identification of Uptravi

No description

Google image searchProduct monograph

Active ingredient

selexipag, 400 MCG

DIN: 02451166

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: JANSSEN INC

Date: 16-DEC-2019

ATC:

• B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
• B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
• B01AC — Platelet aggregation inhibitors excl. heparin (ATC, ATC/DDD)
• B01AC27 — SELEXIPAG (ATC/DDD)

Reference brand drug: Uptravi

External Links for Uptravi

Search on Google

• Uptravi side effects
• Uptravi dosage
• selexipag side effects
• selexipag dosage

Janssen Inc

Go to Janssen website to see drug product details. Sometimes you can find uptravi photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.